Contribute Try STAT+ Today

The Open Society Foundations, one of the world’s largest backers of public health initiatives, is undergoing a “significant” reorganization that will affect grant decision-making, a shift that has created anxiety among advocacy groups that work on access to medicines.

The changes at the OSF, which was founded by billionaire philanthropist George Soros, are still being finalized, although grants will be handled by different OSF offices, according to a foundation spokesperson. She insisted “it is too early to tell” how advocacy groups will be affected, but maintained the contemplated changes may result in “significantly bigger” discretionary funds for public health programming.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment